Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game

Core Viewpoint - Smith+Nephew announces its sponsorship of tennis players at The Championships, Wimbledon 2024, to highlight its advanced Sports Medicine portfolio and commitment to helping individuals recover from injuries and return to their passions [1][9]. Company Overview - Smith+Nephew, founded in 1856 in Hull, UK, operates in over 100 countries and generated annual sales of $5.5 billion in 2023 [4]. - The company focuses on the repair, regeneration, and replacement of soft and hard tissue, aiming to restore individuals' bodies and self-belief through innovative technologies [12]. Sports Medicine Portfolio - Smith+Nephew offers advanced solutions for common tennis injuries, such as rotator cuff tears and meniscus tears, supported by clinical evidence [7]. - The REGENETEN Bioinductive Implant, introduced in 2014, has been used in over 100,000 procedures globally, positively impacting more than 1 million patients annually undergoing rotator cuff surgery [8]. - The FASTFIX Family of meniscal repair solutions has a 30-year legacy, with an 88% mean success rate for all-inside repairs, helping patients recover effectively [8]. Sponsorship Significance - The sponsorship aligns Smith+Nephew with elite athletes, reinforcing its position as a leader in Sports Medicine technology [9]. - The company aims to support athletes in achieving peak performance and recovery through its innovative product offerings [9].